Difficulty: Medium
Average Score: 81%
Practice
The risk of thromboembolic disease associated with use of the combined oral contraceptive is increased in women:(Select one tha does not apply)
Correct answer
D
Rationale
In this question, option D is the correct answer because taking St John's wort can decrease the effectiveness of oral contraceptives, increasing the risk of thromboembolic disease. St John's wort induces the liver enzymes responsible for metabolizing oral contraceptives, leading to decreased serum levels of the contraceptive hormones.
Option A, being over 35 years of age, is a risk factor for thromboembolic disease, especially when combined with oral contraceptives due to increased cardiovascular risk factors in older women.
Option B, smoking, is also a risk factor for thromboembolic disease as smoking increases the risk of blood clots and cardiovascular events.
Option C, having protein C or protein S deficiency, is a risk factor for thromboembolic disease as these proteins are involved in regulating blood clot formation. Deficiencies in these proteins can lead to an increased risk of blood clots.
In an educational context, it is important for healthcare professionals to be aware of the various risk factors associated with oral contraceptive use to provide safe and effective care to their patients. Understanding how different factors can interact to increase the risk of adverse effects is crucial in pharmacology and patient management.
Option A, being over 35 years of age, is a risk factor for thromboembolic disease, especially when combined with oral contraceptives due to increased cardiovascular risk factors in older women.
Option B, smoking, is also a risk factor for thromboembolic disease as smoking increases the risk of blood clots and cardiovascular events.
Option C, having protein C or protein S deficiency, is a risk factor for thromboembolic disease as these proteins are involved in regulating blood clot formation. Deficiencies in these proteins can lead to an increased risk of blood clots.
In an educational context, it is important for healthcare professionals to be aware of the various risk factors associated with oral contraceptive use to provide safe and effective care to their patients. Understanding how different factors can interact to increase the risk of adverse effects is crucial in pharmacology and patient management.